Subscribe to Newsletter

Microscopy and imaging

Inside the Lab Digital and computational pathology

Delivering the Digital Revolution

| Luke Turner

We sit down with Darren Treanor to discover what the digital revolution means for pathologists and how he created the revolutionary Powerwall

Inside the Lab Digital and computational pathology

Pathologist-Centric AI

| Holger Lange and Cris Luengo

Artificial intelligence has a lot to contribute to pathology – but only with the contribution of pathologists who perform analyses no machine can

Subspecialties Biochemistry and molecular biology

Journey to the Center of the Cell

| Luke Turner

A 3D model allows scientists to view live human cells in an unprecedented way, using an algorithm to display the shape and location of its structures

Inside the Lab Microscopy and imaging

The Innovators 2018

Leading industry innovators showcase their newest and most advanced solutions for pathology and laboratory medicine

Outside the Lab Microscopy and imaging

Case of the Month

Can you diagnose this young man's solitary nodule of the lower right lobe and bilateral tree-in-bud opacities?

Inside the Lab Clinical care

From Dream to Deployment

| Sponsored by Leica Biosystems

Leeds Teaching Hospitals NHS Trust and Leica Biosystems have formed a unique partnership to make a 100% digital pathology service a reality

Inside the Lab Clinical care

Characterizing Cancer

| Luke Turner

Digital spatial profiling technology may enable researchers to identify biomarkers that indicate how patients with high-risk melanoma will respond to treatment

Diagnostics Digital and computational pathology

Searching Is Intelligence

| Hamid Tizhoosh

Despite extensive discussion of the benefits of artificial intelligence in pathology, few are talking about one major advantage – image search and retrieval

Inside the Lab Analytical science

Shining a Brighter Light

| Srikanth Singamaneni

A new “plasmonic patch” can enhance fluorescence-based detection and imaging for research and in the clinic

Outside the Lab Clinical care

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register